Jingwu Zhang Zang
Director/Board Member at HH&L ACQUISITION CO.
Net worth: 8 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Yeh | M | 56 |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | 2 years |
| Rajkumar Kannan | M | 61 |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | 1 years |
| Chun Kwok Au | M | 51 | 5 years | |
| Pamela Klein | M | 63 | 4 years | |
| Shuai Chen | M | 50 |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | 1 years |
| Si Hang Ma | M | 72 | 3 years | |
| Yi Fei Zhu | M | 55 |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | 4 years |
| Hua Nan Yang | M | 39 | - | |
| Ruyi He | M | 63 | 3 years | |
| Wei Fu | M | 42 | 6 years | |
| Chia Hung Yang | M | 61 | 4 years | |
| Rong Shao | M | 62 | 3 years | |
| Richard Qi Li | M | 54 | - | |
| Qing Jun Jin | M | 67 | 3 years | |
| Ying Jie Zhong | F | 56 | 4 years | |
| Yun Han Lin | M | 46 | 7 years | |
| Tingliang Yuan | M | 77 |
Shanghai Jiao Tong University
| 42 years |
| Kenneth Hitchner | M | 63 | 3 years | |
| Min Yin | F | - |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | - |
| Andrew Zhu | M | - |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hua Qiong Shen | M | 62 | 4 years | |
| Lin Li | M | 45 |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | 2 years |
| Xiu Xuan Zhu | M | 64 | 3 years | |
| Lei Fang | M | 41 |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | 4 years |
| Wei Zhang | M | 58 |
Shanghai Jiao Tong University
| 7 years |
| Zhi Qing Li | M | 61 |
Shanghai Jiao Tong University
| 4 years |
| Ke Zhong Wu | M | 59 |
Shanghai Jiao Tong University
| 5 years |
| Hui Chen | F | 59 |
Shanghai Jiao Tong University
| 7 years |
| Zheru Zhang | M | 61 | 5 years | |
| Ciska Servais | M | 59 |
Vrije Universiteit Brussel
| 3 years |
| Bing Yuan | M | 55 | - | |
| Laurent Gerard P. Dubois | M | 55 |
Vrije Universiteit Brussel
| 5 years |
| John Long | M | 52 | 1 years | |
| Min Fan | M | 58 |
Shanghai Jiao Tong University
| 7 years |
| Xi Liu | M | 40 | 1 years | |
| Jing Ming Yao | M | 60 |
Shanghai Jiao Tong University
| 4 years |
| Guang Yang | M | 65 |
Shanghai Jiao Tong University
| 4 years |
| Walter Mondt | M | 69 |
Vrije Universiteit Brussel
| 3 years |
| Jian Xiong Liu | M | - |
Shanghai Jiao Tong University
| 4 years |
| Yue Bo Chen | M | 75 |
Shanghai Jiao Tong University
| 4 years |
| Semus Helen | M | - |
Shanghai Jiao Tong University
| 5 years |
| Hui Kang | M | 61 |
Shanghai Jiao Tong University
| 4 years |
| Lan Kang | F | 55 | 3 years | |
| Meng Fang | M | 65 |
Shanghai Jiao Tong University
| 4 years |
| Jie Wen Li | F | 59 |
Shanghai Jiao Tong University
| 4 years |
| Zhi Qiang Chang | M | 61 |
Shanghai Jiao Tong University
| 4 years |
| Jie Yu | M | 49 | - | |
| Zi Min Qian | M | 62 |
Shanghai Jiao Tong University
| 3 years |
| Xiaoye Wu | M | 61 |
Shanghai Jiao Tong University
| 4 years |
| John Hayslip | M | - | 2 years | |
| Mingjie Zhang | M | 60 |
Shanghai Jiao Tong University
| 4 years |
| Weimin Zhu | M | 58 |
Shanghai Jiao Tong University
| 4 years |
| Li Yafei | M | - |
Shanghai Jiao Tong University
| 4 years |
| Gang Cheng | M | 61 |
Shanghai Jiao Tong University
| 4 years |
| Jie Zhang | M | 59 |
Shanghai Jiao Tong University
| 6 years |
| Wei Ming Tang | M | 59 | 6 years | |
| Wei Guo Zhao | M | 69 |
Shanghai Jiao Tong University
| 15 years |
| Jun Ji | M | 60 |
Shanghai Jiao Tong University
| 4 years |
| Alan Au | M | - |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | - |
| Cheng Li | M | 40 | 3 years | |
| Jun Bao | M | 58 |
Glaxosmithkline China Ltd.
| 3 years |
| Anming Zhang | M | - |
Shanghai Jiao Tong University
| 4 years |
| Jie Liu | M | - |
Shanghai Jiao Tong University
| 4 years |
| Zong Min Wu | M | 58 |
Shanghai Jiao Tong University
| 4 years |
| Jian Ping Zheng | M | 60 |
Shanghai Jiao Tong University
| 4 years |
| Wei Lu | M | 55 |
Shanghai Jiao Tong University
| 4 years |
| Tim Gong | M | 60 |
Shanghai Jiao Tong University
| 4 years |
| Ping Hua | M | 61 |
Shanghai Jiao Tong University
| - |
| Yu Chuan Yang | M | 60 |
Shanghai Jiao Tong University
| 4 years |
| Yuan Yi | M | 64 |
Shanghai Jiao Tong University
| 4 years |
| Wenge Yang | M | - |
Shanghai Jiao Tong University
| 3 years |
| Yi Min Lu | M | 61 |
Shanghai Jiao Tong University
| 4 years |
| Joe Chang | M | - |
Shanghai Jiao Tong University
| 4 years |
| Nan Peng Shen | M | 57 |
Shanghai Jiao Tong University
| 4 years |
| Yi Hong Guo | M | 60 |
Shanghai Jiao Tong University
| 4 years |
| Zhi Dong Li | M | 58 |
Shanghai Jiao Tong University
| 4 years |
| André-Xavier Cooreman | M | 60 |
Vrije Universiteit Brussel
| 1 years |
| Wei-min Shen | M | 77 |
Shanghai Jiao Tong University
| 4 years |
| Alex W. Wei | M | 61 |
Shanghai Jiao Tong University
| 4 years |
| J. John Cheng | M | - |
Shanghai Jiao Tong University
| 4 years |
| Zhi Hao Dai | M | 61 |
Shanghai Jiao Tong University
| 4 years |
| Jian Bo Chen | M | 59 |
Shanghai Jiao Tong University
| 4 years |
| Yi Ping Li | M | 59 |
Shanghai Jiao Tong University
| 3 years |
| Jianguo Du | M | 58 |
Shanghai Jiao Tong University
| 4 years |
| Wen Nong Huang | M | 75 |
Shanghai Jiao Tong University
| 4 years |
| Michael He | M | - |
Shanghai Jiao Tong University
| 4 years |
| Feng Mei Ying | F | 70 |
Shanghai Jiao Tong University
| 4 years |
| Jian Wu Yu | M | 67 |
Shanghai Jiao Tong University
| 4 years |
| Wei Jiong Zhang | M | 71 |
Shanghai Jiao Tong University
| 4 years |
| Jun Ni | M | 61 |
Shanghai Jiao Tong University
| 4 years |
| Peter Y. H. Shou | M | - |
Shanghai Jiao Tong University
| 4 years |
| Zi Rong Huang | M | 62 |
Shanghai Jiao Tong University
| 4 years |
| Jian Ping Wang | M | 62 |
Shanghai Jiao Tong University
| 4 years |
| Xiao Long Liu | M | 67 |
Shanghai Jiao Tong University
| 4 years |
| Lawrence Wang | M | - |
Shanghai Jiao Tong University
| 4 years |
| Kokkei Nakayama | M | 60 |
Shanghai Jiao Tong University
| 4 years |
| Fu Min Zhuo | M | 73 |
Shanghai Jiao Tong University
| 4 years |
| Da Qing Nan | M | 65 |
Shanghai Jiao Tong University
| 4 years |
| Ji Hong Qu | M | 60 |
Shanghai Jiao Tong University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 89 | 89.90% |
| Hong Kong | 6 | 6.06% |
| Belgium | 4 | 4.04% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jingwu Zhang Zang
- Personal Network
